U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07616544) titled 'Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization' on May 14.
Brief Summary: 1. Evaluate the efficacy and safety of Qidan Xiaohe granules in patients after coronary revascularization surgery;
2. Develop a traditional Chinese medicine rehabilitation treatment plan and evaluation system for the use of Qidan Xiaohe granules after coronary revascularization surgery;
3. Demonstrate the advantages of traditional Chinese medicine rehabilitation treatment in the postoperative management of coronary revascularization surgery and provide high-level evidence-based medical evidence for...